Evidence map›Paper›PMID 40395323›Full record

ArticleFrontiers in oncology2025

Assessing response in endoscopy images of esophageal cancer treated with total neoadjuvant therapy via hybrid-architecture ensemble deep learning.

Peng Yuan, Meichen Liu, Hangzhou He, Liang Dai, Ya-Ya Wu, Ke-Neng Chen, Qi Wu, Yanye Lu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Peng Yuan *State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Endoscopy Center, Peking University Cancer Hospital and Institute, Beijing, China.
Meichen Liu *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Endoscopy Center, Peking University Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China.
Hangzhou He *Institute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.
Liang Dai *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), The First Department of Thoracic Surgery, Peking University Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China.
Ya-Ya WuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), The First Department of Thoracic Surgery, Peking University Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China.
Ke-Neng ChenKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), The First Department of Thoracic Surgery, Peking University Cancer Hospital and Institute, Peking University School of Oncology, Beijing, China.
Qi WuState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Endoscopy Center, Peking University Cancer Hospital and Institute, Beijing, China.
Yanye LuInstitute of Medical Technology, Peking University Health Science Center, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Esophageal cancer (EC) patients may achieve pathological complete response (pCR) after receiving total neoadjuvant therapy (TNT), which allows them to avoid surgery and preserve organs. We aimed to benchmark the performance of existing artificial intelligence (AI) methods and develop a more accurate model for evaluating EC patients' response after TNT. Methods: We built the Beijing-EC-TNT dataset, consisting of 7,359 images from 300 EC patients who underwent TNT at Beijing Cancer Hospital. The dataset was divided into Cohort1 (4,561 images, 209 patients) for cross-validation and Cohort 2 (2,798 images, 91 patients) for external evaluation. Patients and endoscopic images were labeled as either pCR or non-pCR based on postoperative pathology results. We systematically evaluated mainstream AI models and proposed EC-HAENet, a hybrid-architecture ensembled deep learning model. Results: In image-level classification, EC-HAENet achieved an area under the curve of 0.98 in Cohort 1 and 0.99 in Cohort 2. In patient-level classification, the accuracy of EC-HAENet was significantly higher than that of endoscopic biopsy in both Cohorts 1 and 2 (accuracy, 0.93 Conclusion: EC-HAENet can assist endoscopists in accurately evaluating the response of EC patients after TNT.

Indexed as

deep learningendoscopyesophageal cancerpathological complete responsetotal neoadjuvant therapy

Identifiers

PMID40395323
PMCPMC12089136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.